10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84 | -95.1% | 2,027 | -93.2% | 0.00% | -100.0% |
| Q2 2023 | $1,703 | +10.7% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,539 | +41.7% | 30,000 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $1,086 | -99.9% | 30,000 | -20.0% | 0.00% | 0.0% |
| Q3 2022 | $1,105,000 | -77.4% | 37,500 | -65.2% | 0.00% | -78.6% |
| Q2 2022 | $4,893,000 | +56.2% | 107,800 | +164.9% | 0.01% | +75.0% |
| Q1 2022 | $3,132,000 | -32.2% | 40,687 | +27.0% | 0.01% | -27.3% |
| Q4 2021 | $4,619,000 | -30.2% | 32,049 | -29.4% | 0.01% | -38.9% |
| Q3 2021 | $6,613,000 | +381.6% | 45,379 | +560.2% | 0.02% | +350.0% |
| Q2 2021 | $1,373,000 | +133.1% | 6,874 | +95.7% | 0.00% | +100.0% |
| Q1 2021 | $589,000 | +18.8% | 3,512 | +0.4% | 0.00% | 0.0% |
| Q4 2020 | $496,000 | – | 3,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |